Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Performer
13072.0000 -64.00 (-0.49%)
NSE Apr 22, 2025 15:31 PM
Volume: 32,585
 

13072.00
-0.49%
BP Wealth
Neuland lab (NLL) has posted revenue of INR2,414mn with a 29.6% YoY increase, which was 12% below our estimate of INR 2,160mn. The revenue growth was mainly driven by strong traction in the CMS (54.6% YoY growth) segment, led by 33 molecules (Development + Commercialize) along with...
Number of MF schemes increased from 16 to 23 in Mar 2025 qtr.
More from Neuland Laboratories Ltd.
Recommended